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The Epidemiology of Excess Mortality in
People With Mental Illness
David Lawrence, PhD*; Stephen Kisely, MD, PhD^ Joanne Pais,
Objective: To investigate the burden of excess mortality among people with mental illness in developed
countries, how it is distributed, and whether it has changed over time.
Method: We conducted a systematic search of MEDLINE, restricting our attention to peer-reviewed studies
and reviews published in English relating to mortality and mental illness. Because of the large number of
studies that have been undertaken during the last 30 years, we have selected a representative cross-section of
studies for inclusion in our review.
Results: There is substantial excess mortality in people with mental illness for almost all psychiatric disorders
and all main causes of death. Consistently elevated rates have been observed across settings and over time.
The highest numbers of excess deaths are due to cardiovascular and respiratory diseases. With life
expectancy Increasing in the general population, the disparity in mortality outcomes for people with mental
illness is increasing.
Conclusions: Without the development of alternative approaches to promoting and treating the physical health
of people with mental illness, it is possible that the disparity In mortality outcomes will persist.
Can J Psychiatry. 2010;55(12):752-760.
Clinical Implications
• High mortality rates in people with mental illness highlight the importance of treating both physical illness
and mental disorder in psychiatric patients, particularly cardiovascular and respiratory diseases.
• People with mental illness have not benefited from improvements in life expectancy seen in the general
population, particularly reductions in mortality that are due to cardiovascular disease.
Limitations
• Much of the research on mortality In people with mental illness relies on administrative record linkage.
Thus less is known about the psychosocial, demographic, and lifestyle factors that may modify mortality
risk.
• Excess mortality from natural causes implies either excess morbidity or worse-case outcome, fatality;
however, there has been limited research into the determinants of disease Incidence and prognosis, or
into their prevention.
Key Words: mental health, mortality, cause of death, health status
The excess mortality of people with mental illness has beenknown for many years. In 1841, William Farr' reported to
the Royal Statistical Society on mortality within the major
asylums and licensed houses of the period in England. He esti-
mated, using life-table methods, the mortality rate in the best
facility to be about 3 times that of the general population, and
mortality in other facilities to be several times higher again.
The report inspired the British parliament to require regular
compilation of statistics within all asylums, and established
mortality rate as a measure of the quality of care provided. The
high mortality was attributed to infectious diseases and the
poor conditions within the asylums, such as lack of exercise
and warmth, poor diet, and lack of medical care.
During subsequent years, mortality in people with mental ill-
ness has been the subject of hundreds of studies. In the most
comprehensive meta-analyses to date, Harris and
Barraclough"-^ identified 152 reports on all-cause mortality
and 249 on suicide. They found that all mental disorders were
associated with an increased risk of premature death. Overall
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they estimated a mortality risk of more than double for deaths
owing to natural causes, and almost 10 times for deaths owing
to suieide.
Method and Search Results
We updated Harris and Barraelough's' review of exeess mor-
tality through a systematie search of MEDLINE, for
peer-reviewed studies and reviews published in English on
mortality and mental illness in the 10 years following their
review up to January 2010. Because of the large number of
studies, we restricted the seareh to eore elinieal journals and
focused on overall psychiatric morbidity, as well as mood dis-
orders and schizophrenia. We excluded studies restricted to
dementia, aleohol or substance use, and anorexia nervosa as
inereased mortality may be an integral part of the disease pro-
eess. We used the following seareh terms: psyehiatric disor-
der; mental disorder; affective disorder; depression;
psychosis; schizophrenia; death; and mortality. We did not
include studies that collapsed all adverse events, including
mortality, into one single measure. We also reviewed the bib-
liography of retrieved articles.
Our MEDLINE seareh retrieved 3554 papers, of whieh we
serutinized 135 abstraets (Figure 1). Among these, we
reviewed 104 papers and included 85 in the final review
(Figure 1).
Measures of Excess Mortality
The principal measure is the SMR. Synthesizing SMRs
reported from multiple studies is complicated by the depend-
ence of SMRs on numerous factors that vary between studies.
Relevant faetors inelude follow-up time because the risk of
death from unnatural causes is highest in the period after first
onset of psyehiatrie illness and deelines over time.'*^ A
follow-up cohort of incident eases will return different results
than a follow-up eohort of prevalent eases. The age distribu-
tion of a eohort is also relevant, as unnatural deaths are highest
in younger age groups.''
These issues eomplieate the meta-analyses of mortality stud-
ies. No single estimate of risk can accurately refiect the exeess
risk of mortality with mental illness, as it is clearly dependent
on age, diagnosis, and stage of illness. These dependencies are
only infrequently described,* and life-table methods are use-
ful in this regard.^
Other measures inelude years or potential life lost, average
age at death, and life expeetaney.** For instanee, years of
potential life lost among patients of publie mental health ser-
vices in 8 US states range from 15 to 25 years.** In another
Abbreviations used in this articie
SiVIR standardized mortality ratio
SSRI selective serotonin reuptake inhibitor
study' comparing sex, estimated mean years of potential life
lost were 14 for males and 6 for females.
A further approach is to ealeulate life expectancy or to esti-
mate life tables. To our knowledge, this has only been done in
a Swedish study' where life tables for male and female inpa-
tients were presented by 9 diagnostic categories. Life expec-
tancies were redueed for all diagnostie groups. For example,
at age 40 years, conditional life expeetaney was 7 years less
for patients with sehizophrenia or affective psychosis,
13 years less for substance abuse disorders, and 12 years less
for personality disorders.
Excess Mortality, by Setting
Most mortality studies have been based on either cohorts or
registers of psyehiatric patients. In most eases, these are lim-
ited to people who have received inpatient treatment for men-
tal illness.'" For instanee, Hiroeh et al" followed up a
population of 4.1 million people of whom 258 000 (6%) had
received inpatient treatment for psyehiatrie illness. Mortality
rates were elevated for all psyehiatrie diagnoses, with highest
risks observed for organie psyehoses, dementia, and drug and
aleohol abuse (SMRs around 3). Mortality rates were also
highest for long-stay psychiatric patients." Importantly, the
elevated risk persists for years after discharge from hospital.
Studies of inpatients have beeome less relevant as more psy-
ehiatrie patients are treated in the eommunity. Fortunately,
some psyehiatrie ease registers inelude outpatient and
community-based treatment. For example, Amaddeo et al'^
undertook a 10-year follow-up of over 3000 patients, most of
whom only received outpatient or eommunity-based care.
They estimated an SMR of 2.2 for inpatients and 1.3 for out-
patients.'' A 6-year population follow-up in Nova Seotia
using databases eovering in- and outpatient psyehiatrie ser-
viees and primary eare reported SMRs of around 3 for
patients of speeialist psychiatric services and 1.5 for patients
only treated in general practice.'^
Few studies have examined mortality in population-based
eohorts, and these are generally limited by the relatively
small number of people who are identified as having psyehi-
atrie disorders. Joukamaa et al''' reported an overall relative
risk of mortality of 1.6 in men (95% CI 1.3 to 1.8), and 1.4 in
women (95% CI 1.2 to t .6). Unfortunately, this study did not
break down the cohort by those who did or did not receive
treatment for their mental illness. Bruee et a l" reported a
mortality ratio of 1.4 from a 9-year follow-up of a population
survey ineluding 350 people identified with psyehiatric
disorders.
While these data are not comprehensive, they suggest a gen-
eral pattern of elevated mortality rates across all treatment
settings, with highest mortality ratios for patients with disor-
ders requiring inpatient speeialist treatment, and lower, but
still elevated, ratios in eommunity-based and general practice
settings. It seems likely that people with untreated mental
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Figure 1 Number of papers yielded by search strategy in systematic review
Total papers yielded; 1
abstracts searched 1
electronically for key temis 1
(n = 3554) 1
1
Possible inclusioti; 1
abstracts scrutinized 1
(« = 135) 1
1 1
Papers scrutitiized in detail I
(n=104) 1
Papers in review I
(« - 85) 1
Not meeting inclusion criteria 1
(« = 3419) 1
Not meeting inclusion criteria
(for example, primary focus was
alcohol substance use dementia, or
learning disability)
(« 31)
Excluded 1
(for example, not a prevalence study of
mortality in psychiatric disorder)
(«•= 19)
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disorders also have a higher mortality risk, although this
remains to be more rigorously tested.
Unnatural Causes of Death
Suicide is the most studied cause of death for people with
mental illness, with rates elevated 8 to 14 times among
patients with major depression, schizophrenia, or affective
psychoses.^ While suicide rates are much higher in people
with mental illness than the general community, the absolute
number of deaths are small compared with excess deaths
owing to natural causes, although these have received consid-
erably less attention in the literature.
There is only a small amount of literature on accidental death
and mental illness. In a long-term follow-up of the Danish
psychiatric case register, Hiroeh et al"" found that around 75%
of deaths from unnatural causes in psychiatric patients were
due to suicide, about 25% were accidental deaths, and 1%
were due to homicide. Although the number of deaths are
lower, people with mental illness are at higher risk of acciden-
tal and violent deaths, particularly where drug and alcohol
comorbidities are involved.'^
Natural Causes of Death
The major causes of death in psychiatric patients are chronic
medical diseases not suicide.•' These include circulatory
disorders such as cardiovascular disease and stroke, chronic
lung disease, and infection. Among these, cardiovascular dis-
ease is the most common, and, in contrast to the rate in the
general population, among people with mental illness, the
mortality rate from this cause has not diminished during the
last 2 decades (Figure 2)."'•'^•'*
In the case of cancer, the picture is more complicated. Some
authors have reported lower than expected cancer incidence
or mortality in psychiatric patients, while others have found
no association.''''" Still others have found an increased risk
of incidence or mortality."''^ Schizophrenia has particulariy
been associated with a reduced incidence of cancer.''' Expla-
nations have included a tumour suppressor gene, enhanced
natural killer cell activity, or the protective effects of some
psychotropics."**
Cancer mortality may not always be an ideal marker of the
risk of cancer as it is affected both by susceptibility to
developing the disorder and by subsequent survival rates.
Only 2 population-based studies have evaluated incidence
and mortality at the same time and they showed that while
people with mental illness did not show an increased inci-
dence rate for many types of cancer, they did have higher can-
cer mortality, suggesting a higher cancer case '^
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Figure 2 Ischaemic heart disease mortality rates in Western Australia,
1980-1998"
1980 198? 1984 1986 1988 1990 1992 1994 1996 1998
Year of death
Usan of nwntal hMMh tarvkan: _ _ _ _ Mates —-^- fefnales
Total population -^-^ Males . — f«fnales
' From Lawrence et a l " ; used with permission.
Mortality Risks, by Mental Disorder
Schizophrenia
In 1997, Brown^' published the first meta-analysis of mortal-
ity and schizophrenia, based on 18 studies. He estimated an
SMR of 1.5, and noted that while the highest SMR was seen
for deaths owing to suicide (more than 8), the largest number
of deaths were due to cardiovascular disease. A later
meta-analysis-" based on 37 papers estimated an SMR of 2.5
(95% CI 2.2 to 2.8) with evidence that the SMR for all-cause
mortality has increased in recent decades. The continuing gap
in survival between patients with schizophrenia and the gen-
eral population is confirmed in the latest population-based
cohort study.""''
About one-third of the excess mortality in schizophrenia is
due to unnatural causes, and two-thirds to natural causes.^*"'^
Explanations include direct effects of schizophrenia and its
treatment, as well as poor organization of health services,
stigma within and outside the health system, and attitudes of
medical practitioners.^'
Mood Disorders
Most studies indicate that major depression is associated with
substantial excess mortality.'''** However, results from stud-
ies vary.'"* " While the 1989 US National Health Interview
Study found a mortality risk of 3.1 (95% CI 2.0 to 4.9) for
males and 1.7 (95% CI 0.9 to 3.1 ) for females,^' the Alameda
County study reported no association between depression
and mortality after adjusting for physical comorbidity at
baseline."' These differences may be due to differences in
case definition or length of follow-up. It had been suggested
that mortality risk following depression may wane over sev-
eral years,"* although this in not a universal finding."*
Increased mortality has also been reported for minor as well
as major depression,"*" and a past history of depression can
further increase the risk of inpatient mortality in depressed
patients."*'
There is also a large amount of literature on the link between
depression and death from myocardial infarction.''^ ''^  Sever-
ity or persistence of depression following admission for myo-
cardial infarction had been associated with a doubling of
mortality during subsequent years.'* '^*'"'"*'''* Timing of depres-
sion may also have an influence. Past psychiatric history does
not appear to be as important as depression at the time of
myocardial infarction.'*^ One study''^ also reported that it was
somatic rather than the cognitive or affective depressive
symptoms that were associated with an increased risk of
cardiovascular-related mortality and events. The increased
mortality risk associated with depression extends to unstable
angina,'* '^ heart failure,'- ^^ and cardiac arrhythmias or
arrest.'''" '^* In terms of other disorders, depression has been
linked to increased mortality in stroke,'** chronic obstructive
airways disease,*"" and HIV i
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There have been far fewer studies of bipolar affective disorder
but they also suggest an increased mortality risk from physical
matching that of schizophrenia.*"
Depression in the Elderly
For elderly people with psychotic depression, Vythilingam
et al*^  estimated a mortality ratio of 2.3, while Ganguli et al**
estimated a mortality hazard rate associated with presence of
depressive symptoms of 2.2 after 5 years of follow-up in a
general community sample.
Mortality Risks Over Time
Psychiatric care has changed markedly during the last 30 to 40
years, with the availability of new treatments, moves to com-
munity-based treatment, and the integration of psychiatric and
general medical services. Some of these changes could have
been expected to reduce the level of exposure to some mortal-
ity risks, such as infectious diseases, and to improve access to
physical health care for people with mental illness. At the
same time, other risks could have increased with more free-
dom to make unhealthy lifestyle choices, or experience
adverse social circumstances such as homelessness.*'
As previously noted, the excess mortality of mental illness has
not decreased, and may have increased during this period,*** *''
particularly for cardiovascular and unnatural deaths.™ This is
at a time when mortality from ischaemic heart disease in the
general population has been falling in many developed coun-
tries, such as Australia (Figure 2).
Need for Continued Research
With so many studies of mortality and mental illness, the
value of performing further studies has been questionned.^'
As the excess mortality observed in people with mental illness
has not abated, there is value, at least from a monitoring per-
spective, in continued measurement. However, there are addi-
tional reasons why further research is needed, as much
remains unknown about the mechanisms of excess
mortality.^' Possibilities include the following:
Direct Effects of Mental Illness or Its Treatment
Mental illness may directly affect physical health or the prog-
nosis ofa physical illness. For example, chronic organic brain
syndromes such as dementia are incurable, progressive, and
terminal. Higher mortality could also be associated with the
side effects of treatments such as the cardiovascular and meta-
bolic side effects of psychotropic medications, either directly
or through weight gain.^ ^""* Patients with some diagnoses
such as dementia may be particularly susceptible.'' Although
sudden cardiac death associated with some typical
antipsychotic agents generated concern, patients on typical
and atypical antipsychotics had similar, dose-related
increased risks of sudden cardiac death.'*" Postmenopausal
women taking either tricyclic antidepressants or SSRIs had
increased risks of all-cause mortality, and SSRI users seemed
to be at increased risk of hemorrhagic and fatal stroke,
although absolute risk were low.^' However, the relation
between such events and psychotropic medications may not
always be clear as it is possible that prescription might be a
marker of more severe psychiatric symptoms, or other uncon-
trolled risk *^ *^
Effect of Mental Illness on Lifestyle and Environment
People with mental illness are more likely to smoke, drink
alcohol, and use drugs, to have poorer diets, and are less
likely to exercise at recommended levels.**" ** These lifestyle
factors are linked to obesity and dyslipidemia, insulin resis-
tance and diabetes, and hypertension, which are major risk
factors for cardiovascular disease. Among the total cigarettes
consumed in the United States, 44% were smoked by people
with a mental disorder.**' Similar results have been observed
in Australia, with the 20% of adult Australians who had a
diagnosable mental disorder in the 12 months before the 2007
National Survey of Mental Health and Wellbeing represent-
ing 32.5% of Australian smokers.**" Programs can be success-
ful in helping people with mental illness stop smoking, but
attitudes of practitioners often undermine these programs.****
However, this is unlikely to be the sole explanation in all situ-
ations. All-cause mortality remains high, even after adjusting
for behavioural risk factors such as smoking, physical activ-
ity, and body mass index.**"* In the case of cancer, the inci-
dence at some sites for psychiatric patients is no higher than
that of the general population, although mortality is
higher.-'-' It is unlikely that lifestyle explains this finding,
otherwise incidence should better reflect the increased mor-
tality rate. Although there are less data for other conditions
such as cardiovascular disease, these disorders share similar
risk factors including tobacco, diet, and alcohol.
Effect of Mental Illness on Physical Health Care
People with mental illness are generally less likely to receive
the same level of health care as others in the community with
the same level of physical health problems.^ •^•'" Despite the
higher incidence of cardiovascular disease, rates of proce-
dural interventions are considerably lower in people with
mental illness, in Australia, Canada, the United States, and
Denmark. '*•'*'" They are also less likely to receive appropri-
ate medications on discharge such as beta blockers and
statins.'" The results are consistent with findings from ambu-
latory and primary care where patients with severe mental ill-
ness were less likely to be assessed or treated for
hyperlipidaemia.'^"* The few exceptions to these findings
are in highly specific groups such as patients of Veterans
Affairs.^' A follow-up of older patients after acute myocar-
dial infarction found that while mental disorders were associ-
ated with higher mortality risks, this dependence disappeared
once measures of quality of the medical care they received
were factored into the model.'**
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It is possible that physicians are reluctant to offer some proee-
dures because of the ensuing psychological stress, concerns
about capacity or compliance with postoperative care, or the
presence of eontraindieations sueh as smoking.''' In addition,
psyehiatrie patients may be more at risk of developing eompli-
eations following medical or surgical interventions,'"" or to
have poorer outcomes postoperatively."" However, contra-
indications to speeialized interventions, sueh as smoking or
problems with informed consent, are less relevant to the pre-
scription of vascular drugs such as angiotensin-eonverting
enzyme inhibitors, beta blockers, or statins known to reduce
subsequent morbidity and mortality. It seems that while we
are willing to make considerable accommodations to allow
people with physical limitations to access health care, there
may be a different attitude in terms of accommodating the
needs of people with mental illness who may have resulting
cognitive impairments that could impair their access to, or
compliance with, medical eare.
In the case of eaneer, a higher mortality in the context of an
incidence that is no higher than the general population might
be explained by delays in detection or initial presentation,
with more advanced staging at presentation.
While it is possible to improve the physieal health of people
with mental illness, developing programs and models of care
that allow for the cognitive, social, and functional impair-
ments assoeiated with mental illness would seem to be an
important step forward.'"^
Research Directions
Research in this area has been hampered by the long follow-up
times and large cohort sizes required to capture sufficiently
large numbers of events for informative analysis. Numerous
locations now have long-running population-based registers
or administrative data that can be used to track mortality and
other outcomes in people with mental illness. However, most
are limited in the breadth of the information they collect, with
little details available about comorbidities, substance use,
diet, exercise, and other lifestyle factors, or social, economic,
or demographic faetors that would be of interest in exploring
the various hypotheses for exeess mortality.
Another limitation of administrative data, and register- and
hospital-based researeh is that less than one-half of people
with diagnosable psyehiatrie disorders seek treatment.^ '''^ '^
Little is therefore known about whether there is exeess mortal-
ity in the eommunity owing to untreated mental illness. This
deficiency could be addressed by combining large-scale
cross-sectional surveys in the community (and thus including
people with treated and untreated psychiatric morbidity), with
longitudinal follow-up via linkage to mortality registers.
A final area that is underrepresented in the literature is inter-
vention research. Regarding primary prevention, there have
been few attempts to address risk factors for physical illness in
people with mental illness. In a trial of physical health checks
and health promotion for patients with severe mental illness,
two-thirds of the trial group had not recently undergone any
physieal health eheek despite most having at least one modi-
fiable first faetor for eardiovaseular disease."" Although the
program was well reeeived by the partieipants, its effeetive-
ness was not evaluated. Similarly, interventions for smoking,
sueh as nieotine replacement therapy and buproprion, show
promise, but there has been mueh less research than in the
general population.'"" In addition, studies have largely been
restricted to psychiatric patients in remission, and data are
also lacking for medications such as vareniclinc in this
group. '"" Regarding secondary prevention, results have been
disappointing.'"'^ The Sertraline AntiDepressant Heart
Attack Trial investigation demonstrated that sertraline is safe
and efficacious in depressed patients with ischémie heart dis-
ease but was underpowered to detect a mortality difference
between sertraline and placebo.""' Similarly, in patients with
ehronie obstructive pulmonary disease and depression,
appropriate psyehotropie treatment was not signifieantly
associated with decreased mortality during the following
2 years.'"' Larger studies are therefore needed that incorpo-
rate both psychological and pharmacological therapy for
depression.
Conclusions
Almost all reports of psychiatric and physical comorbidity
have found excess mortality associated with mental illness,
for all psychiatric diagnoses considered, across all settings,
and at all ages. Elevated mortality rates have been reported
for all major causes of death, with cardiovascular disease
being the most common cause of premature death. Without
the development of altemative approaches to promoting and
treating the physieal health of people with mental illness, it is
possible this disparity will persist.
Risk faetors for eardiovaseular disease (and other major natu-
ral causes of death), such as smoking, obesity, and hyperten-
sion, are potentially modifiable. There have been extensive
efforts to modify risk factors in the general population (such
as antismoking campaigns, modification of diets, and
increasing promotion of physical activity), and at least some
of the decline in cardiovascular mortality observed in the
developed world has been attributed to these factors. In con-
trast, there have been few attempts to address these factors in
people with mental illness. Antismoking groups, national
heart associations, diabetes associations, and cancer associa-
tions should realize that psychiatric patients are a significant
proportion of their target audience, and that tailored interven-
tions are required to address their specific needs. Researeh
into ways to improve health care and health promotion in
populations with mental illness has the potential to address
the excess of mortality associated with mental illness.
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In Review
Résumé : L'épidémiologie du taux de mortalité excessif chez les personnes
souffrant de maladie mentale
Objectif : Examiner le fardeau du taux de mortalité excessif chez les personnes souffrant de maladie
mentale dans les pays développés, la façon dont il est distribué, et s'il a changé avec le temps.
Méthode : Nous avons mené une recherche systématique dans MEDLINE, limitant notre attention
aux études révisées par les pairs et aux revues publiées en anglais portant sur la mortalité et la
maladie mentale. En raison du grand nombre d'études qui ont été entreprises durant les 30 dernières
années, nous avons choisi un échantillon représentatif des études à inclure dans notre revue.
Résultats : 11 y a un taux de mortalité excessif substantiel chez les personnes souffrant de maladie
mentale pour presque tous les troubles psychiatriques et toutes les principales causes de décès.
Des taux constamment élevés ont été observés dans tous les milieux et au fil du temps. Les taux les
plus élevés de décès excessifs sont attribuables aux maladies cardiovasculaires et respiratoires.
Tandis que l'espérance de vie s'accroît dans la population générale, la disparité des décès pour les
personnes souffrant de maladie mentale augmente.
Conclusions : Si l'on n'élabore pas des approches de rechange pour promouvoir et traiter la santé
physique des personnes souffrant de maladie mentale, il est possible que la disparité des décès
persiste.
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